Collection

ACMD drug-specific reports

This series brings together all documents relating to ACMD drug-specific reports.

• From: Advisory Council on the Misuse of Drugs
• Published: 4 June 2013

The Advisory Council carries out in-depth reviews of specific drugs, including their classification under the Misuse of Drugs Act 1971.

Documents

• Ketamine: rescheduling and patient group directions
  • 17 February 2015
  • Policy paper
• Ketamine report
  • 10 December 2013
  • Policy paper
• Temporary class drug order on benzofury and NBOMe compounds - letter from ACMD
  • 4 June 2013
  • Correspondence
• ACMD advice on tramadol
  • 13 February 2013
  • Research and analysis
• ACMD advice on independent prescribing of controlled drugs
  • 13 February 2013
  • Guidance
• Khat report 2013
  • 12 February 2013
  • Research and analysis
• ACMD - Recovery from drug and alcohol dependence: an overview of the evidence (2012)
  • 9 January 2013
  • Research and analysis
• Advisory Council on the Misuse of Drugs (ACMD) Methoxetamine report, 2012
  • 18 October 2012
  • Policy paper
• Novel psychoactive substances report (2011)
  • 25 October 2011
  • Research and analysis
• ACMD report on desoxypipradrol
  • 13 September 2011
  • Correspondence
• Foil report
  • 10 November 2010
  • Research and analysis
• Advisory Council on the Misuse of Drugs: Consideration of the anabolic steroids
  • 21 September 2010
  • Corporate report
• Advisory Council on the Misuse of Drugs: Consideration of the anabolic steroids
  • 21 September 2010
  • Research and analysis
• Advisory Council on the Misuse of Drugs Naphyrone Report (2010)
  • 7 July 2010
  • Research and analysis
• ACMD report on the consideration of the cathinones
  • 31 March 2010
  • Policy paper
• ACMD report on the major cannabinoid agonists
  • 12 August 2009
  • Independent report
• ACMD 1-benzylpiperazine (BZP) Report (2008)
  • 21 May 2009
  • Independent report
• MDMA ('ecstasy') review
  • 11 February 2009
  • Guidance
• ACMD report on gamma-butyrolactone (GBL)
  • 6 August 2008
  • Guidance
• ACMD: Cannabis classification and Public Health (2008)
  • 7 May 2008
  • Corporate report
• ACMD Drug Facilitated Sexual Assault (DFSA) (2007)
  • 2 April 2007
  • Corporate report
• Khat Report 2005
  • 19 January 2006
  • Corporate report
• The Advisory Council’s report - Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971 (2005)
  • 19 January 2006
  • Corporate report
• ACMD's latest Methylamphetamine Advice
  • 19 December 2005
  • Guidance
• Advisory Council on the Misuse of Drugs Methylamphetamine review 2005 executive summary
  • 17 November 2005
  • Research and analysis
• Appendix One: Forensic Science Service – Methylamphetamine
  • 31 October 2004
  • Corporate report
• The classification of Cannabis under the Misuse of Drugs Act 1971 (2002)
  • 31 March 2003
  • Policy paper

Published 4 June 2013